Ignite Creation Date:
2024-05-06 @ 5:59 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05509478
Status:
UNKNOWN
Last Update Posted:
2022-09-10
First Post:
2022-08-18
Brief Title:
Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for UnresectableAdvanced Biliary Tract Carcinoma
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University